Platelet-specific proteins in patients with transient ischemic attacks - Effects of anti-platelet drugs

Fabrizio Fabris, Maria Luigia Randi, Maria Elena Crociani, Sergio Manzoni, Paolo Tonin, Luciano De Zanche, Giuseppe Cella, Antonio Girolami

Research output: Contribution to journalArticlepeer-review

Abstract

Levels of β-thromboglobulin and platelet factor 4 in 46 patients with transient ischemic attacks and the influence of treatment with dipyridamole or aspirin plus dipyridamole were evaluated. Patients not receiving therapy showed levels of β-thromboglobulin significantly higher than controls. However, patients taking only dipyridamole showed values of β-thromboglobulin significantly lower than untreated patients or those taking aspirin plus dipyridamole. No significant difference was observed with regard to platelet factor 4 between the patients.

Original languageEnglish
Pages (from-to)437-442
Number of pages6
JournalLa Ricerca in Clinica e in Laboratorio
Volume13
Issue number4
DOIs
Publication statusPublished - Oct 1983

Keywords

  • β-thromboglobulin
  • Anti-platelet drugs
  • Aspirin
  • Dipyridamole
  • Platelet factor 4
  • Platelet-specific proteins
  • Transient ischemic attacks

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Platelet-specific proteins in patients with transient ischemic attacks - Effects of anti-platelet drugs'. Together they form a unique fingerprint.

Cite this